Retained Earnings (Accumulated Deficit) of Co-Diagnostics, Inc. from 31 Dec 2016 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Co-Diagnostics, Inc. quarterly Retained Earnings (Accumulated Deficit) in USD history and change rate from 31 Dec 2016 to 30 Sep 2025.
  • Co-Diagnostics, Inc. Retained Earnings (Accumulated Deficit) for the quarter ending 30 Sep 2025 was $54,191,053, a 146% decline year-over-year.
Source SEC data
View on sec.gov
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Change (%)

Co-Diagnostics, Inc. Quarterly Retained Earnings (Accumulated Deficit) (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $54,191,053 -$32,181,403 -146% 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 $48,304,230 -$35,991,035 -292% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $40,574,113 -$35,860,236 -761% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $33,040,842 -$37,639,008 -819% 31 Dec 2024 10-Q 13 Nov 2025 2025 Q3
Q3 2024 $22,009,650 -$41,284,271 -214% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $12,313,195 -$37,570,010 -149% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $4,713,877 -$38,889,517 -114% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $4,598,166 -$35,332,865 -88% 31 Dec 2023 10-K 27 Mar 2025 2024 FY
Q3 2023 $19,274,621 -$42,561,889 -69% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $25,256,815 -$37,940,757 -60% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $34,175,640 -$31,708,234 -48% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $39,931,031 -$14,238,248 -26% 31 Dec 2022 10-K 14 Mar 2024 2023 FY
Q3 2022 $61,836,510 +$15,165,641 +32% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 $63,197,572 +$28,002,669 +80% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 $65,883,874 +$40,474,184 +159% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $54,169,279 +$36,658,564 +209% 31 Dec 2021 10-K 16 Mar 2023 2022 FY
Q3 2021 $46,670,869 +$41,967,335 +892% 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 $35,194,903 +$46,222,901 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $25,409,690 +$51,442,697 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 $17,510,715 +$42,478,529 31 Dec 2020 10-K 24 Mar 2022 2021 FY
Q3 2020 $4,703,534 +$27,858,252 30 Sep 2020 10-Q 16 Nov 2020 2020 Q3
Q2 2020 $11,027,998 +$10,378,954 +48% 30 Jun 2020 10-Q/A 03 Nov 2020 2020 Q2
Q1 2020 $26,033,007 -$5,970,451 -30% 31 Mar 2020 10-Q 14 May 2020 2020 Q1
Q4 2019 $24,967,814 -$6,273,647 -34% 31 Dec 2019 10-K 25 Mar 2021 2020 FY
Q3 2019 $23,154,718 -$6,408,719 -38% 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 $21,406,952 -$6,302,098 -42% 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 $20,062,556 -$6,329,879 -46% 31 Mar 2019 10-Q 14 May 2019 2019 Q1
Q4 2018 $18,694,167 -$6,271,723 -50% 31 Dec 2018 10-K 30 Mar 2020 2019 FY
Q3 2018 $16,745,999 -$5,828,531 -53% 30 Sep 2018 10-Q 14 Nov 2018 2018 Q3
Q2 2018 $15,104,854 -$8,080,893 -115% 30 Jun 2018 10-Q 10 Aug 2018 2018 Q2
Q1 2018 $13,732,677 31 Mar 2018 10-Q 14 May 2018 2018 Q1
Q4 2017 $12,422,444 -$6,959,232 -127% 31 Dec 2017 10-K 01 Apr 2019 2018 FY
Q3 2017 $10,917,468 30 Sep 2017 10-Q 14 Nov 2017 2017 Q3
Q2 2017 $7,023,961 30 Jun 2017 10-Q 25 Aug 2017 2017 Q2
Q4 2016 $5,463,212 31 Dec 2016 10-K 28 Mar 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.